Johnson & Johnson agrees to buy Synthes

Johnson & Johnson agrees to buy Synthes

Pharmaceutical, multinational medical devices and consumer packaged goods manufacturer Johnson & Johnson agrees to buy Synthes, the medical device maker for $19.7 Billion in cash and stock deal. “The completion of the Synthes acquisition creates the world’s most innovative and comprehensive orthopaedics business and reflects our long-standing strategy of leadership within attractive health care markets,”…

Read More...